Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) (2022)
- Authors:
- Autor USP: ABRÃO, MAURICIO SIMÕES - FM
- Unidade: FM
- DOI: 10.1016/S0140-6736(22)00622-5
- Subjects: CO-TERAPIA; GONADOTROFINAS; ENDOMETRIOSE; PLACEBOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
GIUDICE, Linda C et al. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet, v. 399, n. 10343, p. 2267-2279, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)00622-5. Acesso em: 10 jun. 2024. -
APA
Giudice, L. C., As-sanie, S., Ferreira, J. C. A., Becker, C. M., Abrão, M. S., Lessey, B. A., et al. (2022). Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet, 399( 10343), 2267-2279. doi:10.1016/S0140-6736(22)00622-5 -
NLM
Giudice LC, As-sanie S, Ferreira JCA, Becker CM, Abrão MS, Lessey BA, Brown E, Dynowski K, Wilk K, Li Y. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) [Internet]. Lancet. 2022 ; 399( 10343): 2267-2279.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/S0140-6736(22)00622-5 -
Vancouver
Giudice LC, As-sanie S, Ferreira JCA, Becker CM, Abrão MS, Lessey BA, Brown E, Dynowski K, Wilk K, Li Y. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) [Internet]. Lancet. 2022 ; 399( 10343): 2267-2279.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/S0140-6736(22)00622-5 - Fertility-sparing treatment of adenomyosis in patients with infertility: a systematic review of current options
- Structured ultrasound and magnetic resonance imaging reports for patients with suspected endometriosis: guide for imagers and clinicians
- Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain
- Extrapelvic Endometriosis: A Systematic Review
- Macrophage Immune Memory Controls Endometriosis in Mice and Humans
- Stem cells in endometrium and their role in the pathogenesis of endometriosis
- Importância da avaliação da qualidade de vida em pacientes com endometriose
- Common chromosomal imbalances and stemness-related protein expression markers in endometriotic lesions from different anatomical sites: the potential role of stem cells
- Seven ways to preserve female fertility in patients with endometriosis
- Endometriose
Informações sobre o DOI: 10.1016/S0140-6736(22)00622-5 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
